Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 231, doi. 10.1007/s00228-004-0767-7
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2004 AND VI 60 AND IP 4
Results: 12
1
2
Thrombocytopenia and fatality associated with olanzapine.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 295, doi. 10.1007/s00228-004-0772-x
- By:
- Publication type:
- Article
3
Effects of SCH27899 (Ziracin), an oligosaccharide everninomicin antibiotic, on urate kinetics in humans.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 255, doi. 10.1007/s00228-004-0755-y
- By:
- Publication type:
- Article
4
Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 285, doi. 10.1007/s00228-004-0760-1
- By:
- Publication type:
- Article
5
Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 279, doi. 10.1007/s00228-004-0761-0
- By:
- Publication type:
- Article
6
Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 265, doi. 10.1007/s00228-004-0763-y
- By:
- Publication type:
- Article
7
Comparison of the pharmacokinetics of fosfluconazole and fluconazole after single intravenous administration of fosfluconazole in healthy Japanese and Caucasian volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 247, doi. 10.1007/s00228-004-0764-x
- By:
- Publication type:
- Article
8
No urine, no urinary clearance.
- Published in:
- 2004
- By:
- Publication type:
- Erratum
9
Oral administration of a low dose of midazolam (75 μg) as an in vivo probe for CYP3A activity.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 237, doi. 10.1007/s00228-004-0762-z
- By:
- Publication type:
- Article
10
Restricted indications for the use of antibiotics in acute otitis media.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 293, doi. 10.1007/s00228-004-0771-y
- By:
- Publication type:
- Article
11
Pregraduate teaching clinical pharmacology in Germany.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 225, doi. 10.1007/s00228-004-0750-3
- By:
- Publication type:
- Article
12
The pharmacokinetics of eflornithine (α-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 269, doi. 10.1007/S00228-004-0759-7
- By:
- Publication type:
- Article